Rabi Hanna: Gene Therapy Is Transforming Sickle Cell Disease
Rabi Hanna, Chairman, Department of Pediatric hematology-oncology and BMT at Cleveland Clinic Children’s at Cleveland Clinic, shared a post on LinkedIn:
“Today, on World Sickle Cell Day, I had the distinct honor of speaking at the Dutch Sickle Cell event in Amsterdam.
A special thank you to Erfan Nur for the invitation and the opportunity to join this critical conversation. It is a privilege to present an update on the rapidly evolving landscape of sickle cell gene therapy
While the scientific advancements we are seeing are groundbreaking, our work is far from finished.
The true measure of our success will be ensuring that these potentially curative treatments are accessible to everyone who needs them, regardless of geography or socioeconomic status.
Thank you to the Dutch SCD community for hosting such an inspiring event. Let’s continue pushing the boundaries of science while fighting for equitable care.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge